<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis E virus (HEV) infection is an important and emerging public health issue associated with considerable morbidity and mortality. In the past, its impact was thought to be limited to developing countries, where it caused epidemics due to water contamination and poor sanitation [
 <xref rid="B1-pathogens-09-00137" ref-type="bibr">1</xref>]. Today it is known to be endemic in most high-income countries as a zoonotic disease with pigs as the primary reservoir [
 <xref rid="B2-pathogens-09-00137" ref-type="bibr">2</xref>]. HEV infection is the major cause of acute viral hepatitis in many European countries, with more reported cases than acute hepatitis A or B [
 <xref rid="B3-pathogens-09-00137" ref-type="bibr">3</xref>]. Acute HEV infection is often asymptomatic in immunocompetent individuals; its clinical manifestation ranges from mild hepatitis to acute (on chronic) liver failure (A(C)LF) [
 <xref rid="B2-pathogens-09-00137" ref-type="bibr">2</xref>,
 <xref rid="B4-pathogens-09-00137" ref-type="bibr">4</xref>,
 <xref rid="B5-pathogens-09-00137" ref-type="bibr">5</xref>]. It has also been associated with extrahepatic manifestations, mostly neurological but also musculoskeletal, hematological and renal [
 <xref rid="B6-pathogens-09-00137" ref-type="bibr">6</xref>].
</p>
